21
TITLE: ON DEATH AND DYING: CULTURAL END-OF-LIFE ISSUES IN MULTIPLE MYELOMA  Full Text
AUTHORS: Pereira, M; Ruzickova, L; Geraldes, C; Ribeiro, L;
PUBLISHED: 2015, SOURCE: 20th Congress of European-Hematology-Association in HAEMATOLOGICA, VOLUME: 100
INDEXED IN: WOS
22
TITLE: Vascular Endothelial Growth Factor Expression in CD138+/CD19-and CD138+/CD19+Plasma Cells in Monoclonal Gammopathies and Impact on Multiple Myeloma Prognosis
AUTHORS: Catarina Geraldes; Ana Cristina Gonçalves ; Raquel Alves; Emilia Cortesao; Maria Leticia Ribeiro; Jose Nascimento Costa; Ana Bela Sarmento Ribeiro;
PUBLISHED: 2015, SOURCE: 55th Annual Meeting and Exposition of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: WOS
23
TITLE: Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
AUTHORS: Lotfi Benboubker; Meletios A Dimopoulos; Angela Dispenzieri; John Catalano; Andrew R Belch; Michele Cavo; Antonello Pinto; Katja Weisel; Heinz Ludwig; Nizar Bahlis; Anne Banos; Mourad Tiab; Michel Delforge; Jamie Cavenagh; Catarina Geraldes; Je Jung Lee; Christine Chen; Albert Oriol; Javier de la Rubia; Lugui G Qiu; Darrell J White; Daniel Binder; Kenneth Anderson; Jean Paul Fermand; Philippe Moreau; Michel Attal; Robert Knight; Guang Chen; Jason Van Oostendorp; Christian Jacques; Annette Ervin Haynes; Herve Avet Loiseau; Cyrille Hulin; Thierry Facon; ...More
PUBLISHED: 2014, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 371, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef
25
TITLE: European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization. PLERIXAFOR IN NONHEMATOLOGIC DISEASES  Full Text
AUTHORS: Nina Worel; Jane F Apperley; Grzegorz W Basak; Kenneth W Douglas; Ian H Gabriel; Catarina Geraldes; Kai Huebel; Ozren Jaksic; Zdenek Koristek; Francesco Lanza; Roberto Lemoli; Gabor Mikala; Dominik Selleslag; Rafael F Duarte; Mohamad Mohty;
PUBLISHED: 2012, SOURCE: TRANSFUSION, VOLUME: 52, ISSUE: 11
INDEXED IN: WOS CrossRef
26
TITLE: Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF  Full Text
AUTHORS: Basak, GW; Wiktor Jedrzejczak, W; Apperley, JF; Douglas, KW; Gabriel, IH; Geraldes, C; Huebel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Selleslag, D; Worel, N; Mohty, M; Duarte, RF;
PUBLISHED: 2012, SOURCE: BONE MARROW TRANSPLANTATION, VOLUME: 47, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef
27
TITLE: Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide
AUTHORS: Florent Malard; Nicolaus Kroeger; Ian H Gabriel; Kai Huebel; Jane F Apperley; Grzegorz Basak; Kenneth W Douglas; Catarina Geraldes; Ozren Jaksic; Zdenek Koristek; Francesco Lanza; Roberto M Lemoli; Gabor Mikala; Dominik Selleslag; Nina Worel; Rafael F Duarte; Mohamad Mohty;
PUBLISHED: 2011, SOURCE: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis in BLOOD, VOLUME: 118, ISSUE: 21
INDEXED IN: WOS
28
TITLE: Lipoatrophic diabetes: Case report [Diabetes lipoatrófica: Caso clínico]
AUTHORS: Martins, T; Bastos, M; Tome, L; Lemos, M; Batista, C; Carvalheiro, M; Ruas, MMA;
PUBLISHED: 2003, SOURCE: Arquivos de Medicina, VOLUME: 17, ISSUE: 1-3
INDEXED IN: Scopus
Page 3 of 3. Total results: 28.